Stay updated on Elranatamab Combo in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Elranatamab Combo in Myeloma Clinical Trial page.

Latest updates to the Elranatamab Combo in Myeloma Clinical Trial page
- Check6 days agoChange DetectedThe page has updated its revision number to v2.16.5 and added new recruiting dates for July 2025, while removing previous dates and information about the ClinicalTrials.gov data ingest modernization.SummaryDifference1%
- Check13 days agoChange DetectedThe page has updated its recruiting status, indicating that it is now actively recruiting as of June 23, 2025, and has removed the previous note stating it was not yet recruiting. Additionally, a date has been added for June 24, 2025.SummaryDifference0.5%
- Check20 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.7%
- Check28 days agoChange DetectedThe webpage has updated its date information, reflecting new dates in June 2025 while removing older dates from May 2025.SummaryDifference0.4%
- Check35 days agoChange DetectedThe page has updated the number of study locations from 64 to 65 and added a new location in Aviano, Italy. Additionally, the revision number has been updated from v2.16.1 to v2.16.2.SummaryDifference0.6%
- Check42 days agoChange DetectedThe page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
Stay in the know with updates to Elranatamab Combo in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elranatamab Combo in Myeloma Clinical Trial page.